SUSMED has announced that it, together with Nagoya City University, has begun development of Digital Therapeutics (DTx) for functional disorders. This DTx will be developed by combining expertise of Nagoya City University in treatment of chronic pain with Acceptance and Commitment Therapy, and SUSMED’s experience and its patented technology in DTx development.